Javier Blasco‐Alonso

1.7k total citations
47 papers, 610 citations indexed

About

Javier Blasco‐Alonso is a scholar working on Epidemiology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Javier Blasco‐Alonso has authored 47 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Genetics and 10 papers in Clinical Biochemistry. Recurrent topics in Javier Blasco‐Alonso's work include Metabolism and Genetic Disorders (10 papers), Inflammatory Bowel Disease (7 papers) and Mitochondrial Function and Pathology (6 papers). Javier Blasco‐Alonso is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Inflammatory Bowel Disease (7 papers) and Mitochondrial Function and Pathology (6 papers). Javier Blasco‐Alonso collaborates with scholars based in Spain, United Kingdom and India. Javier Blasco‐Alonso's co-authors include Víctor Manuel Navas‐López, Beatriz Espín, Jaime Dalmau, Carlos Sierra, David Gil, María L. Couce, Luis Aldámiz‐Echevarría, Rosaura Leis, J. Maldonado and Isidro Vitoria and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and Clinical Nutrition.

In The Last Decade

Javier Blasco‐Alonso

45 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Blasco‐Alonso Spain 14 167 151 145 141 132 47 610
J.-L. Bresson France 11 85 0.5× 63 0.4× 70 0.5× 133 0.9× 19 0.1× 23 477
J. Roberto Moran United States 15 73 0.4× 29 0.2× 105 0.7× 277 2.0× 71 0.5× 29 739
Giusy Ranucci Italy 15 100 0.6× 47 0.3× 78 0.5× 358 2.5× 69 0.5× 46 767
Ilan Kochba Israel 8 180 1.1× 26 0.2× 179 1.2× 44 0.3× 90 0.7× 11 809
Renata Pomahačová Czechia 13 125 0.7× 73 0.5× 83 0.6× 63 0.4× 358 2.7× 41 834
Stefaan Peeters Belgium 12 62 0.4× 24 0.2× 54 0.4× 137 1.0× 34 0.3× 22 493
John E. Van Aerde Canada 15 71 0.4× 62 0.4× 111 0.8× 786 5.6× 34 0.3× 21 964
Sohsaku Yamanouchi Japan 16 199 1.2× 11 0.1× 127 0.9× 50 0.4× 28 0.2× 52 661
Dost Zeyrek Türkiye 14 54 0.3× 30 0.2× 133 0.9× 54 0.4× 16 0.1× 32 491
Neslihan Tekın Türkiye 13 120 0.7× 19 0.1× 72 0.5× 122 0.9× 40 0.3× 61 578

Countries citing papers authored by Javier Blasco‐Alonso

Since Specialization
Citations

This map shows the geographic impact of Javier Blasco‐Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Blasco‐Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Blasco‐Alonso more than expected).

Fields of papers citing papers by Javier Blasco‐Alonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Blasco‐Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Blasco‐Alonso. The network helps show where Javier Blasco‐Alonso may publish in the future.

Co-authorship network of co-authors of Javier Blasco‐Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Blasco‐Alonso. A scholar is included among the top collaborators of Javier Blasco‐Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Blasco‐Alonso. Javier Blasco‐Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heras, Javier de las, Javier Blasco‐Alonso, Mafalda Bourbon, et al.. (2024). Practical Recommendations for the Diagnosis and Management of Lysosomal Acid Lipase Deficiency with a Focus on Wolman Disease. Nutrients. 16(24). 4309–4309. 3 indexed citations
2.
Remón-Ruiz, Pablo, et al.. (2022). Cardiometabolic and Nutritional Morbidities of a Large, Adult, PKU Cohort from Andalusia. Nutrients. 14(6). 1311–1311. 15 indexed citations
3.
Martín‐Masot, Rafael, et al.. (2021). Sirolimus for the Treatment of Juvenile Polyposis in Childhood. ACG Case Reports Journal. 8(8). e00646–e00646. 3 indexed citations
4.
Yahyaoui, Raquel, Javier Blasco‐Alonso, Carmen Benito, et al.. (2020). Metabolic Serendipities of Expanded Newborn Screening. Genes. 11(9). 1018–1018. 8 indexed citations
5.
Benito, Carmen, Javier Blasco‐Alonso, Pilar Caro, et al.. (2019). Initial Evaluation of Prospective and Parallel Assessments of Cystic Fibrosis Newborn Screening Protocols in Eastern Andalusia: IRT/IRT versus IRT/PAP/IRT. International Journal of Neonatal Screening. 5(3). 32–32. 4 indexed citations
6.
Martín‐Masot, Rafael, et al.. (2019). Central Venous Sinus Thrombosis in a Boy With Acute Severe Ulcerative Colitis. Frontiers in Pediatrics. 7. 19–19. 5 indexed citations
7.
8.
Pintos‐Morell, Guillem, Javier Blasco‐Alonso, María L. Couce, et al.. (2018). Elosulfase alfa for mucopolysaccharidosis type IVA: Real-world experience in 7 patients from the Spanish Morquio-A early access program. Molecular Genetics and Metabolism Reports. 15. 116–120. 11 indexed citations
9.
Merinero, B., Patricia Alcaide, Elena Martín‐Hernández, et al.. (2017). Four Years’ Experience in the Diagnosis of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency in Infants Detected in Three Spanish Newborn Screening Centers. JIMD Reports. 39. 63–74. 22 indexed citations
10.
Couce, María L., Luis Aldámiz‐Echevarría, Amaya Bélanger-Quintana, et al.. (2016). Genotype and phenotype characterization in a Spanish cohort with isovaleric acidemia. Journal of Human Genetics. 62(3). 355–360. 14 indexed citations
11.
Aldámiz‐Echevarría, Luis, Marta Llarena, Jaime Dalmau, et al.. (2016). Molecular epidemiology, genotype–phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria. Journal of Human Genetics. 61(8). 731–744. 29 indexed citations
12.
Blasco‐Alonso, Javier, et al.. (2016). Metastatic Crohns disease in pediatrics. Revista Española de Enfermedades Digestivas. 108(9). 598–603. 5 indexed citations
13.
Blasco‐Alonso, Javier, et al.. (2015). Prognostic indicators after cardiac surgery in children and their relationship with the oxidative stress response. Revista Española de Anestesiología y Reanimación (English Edition). 63(1). 3–12. 7 indexed citations
14.
Blasco‐Alonso, Javier, et al.. (2015). Indicadores pronósticos clínicos en el posoperatorio de cirugía cardiovascular pediátrica y su relación con la cinética del estrés oxidativo. Revista Española de Anestesiología y Reanimación. 63(1). 3–12. 7 indexed citations
15.
Blasco‐Alonso, Javier, et al.. (2014). Acute alithiasic cholecystitis: a not so rare disease.. PubMed. 106(7). 487–90. 3 indexed citations
16.
Navas‐López, Víctor Manuel, et al.. (2014). La nutrición enteral exclusiva continua siendo el tratamiento de primera línea en la enfermedad de Crohn pediátrica en la era de los biológicos. Anales de Pediatría. 83(1). 47–54. 16 indexed citations
17.
Navas‐López, Víctor Manuel, et al.. (2014). Successful treatment for ulcerative proctitis with rectal tacrolimus in an 8-year-old girl with intolerance to mesalamine. Clinical Journal of Gastroenterology. 7(4). 320–323. 3 indexed citations
18.
Aldámiz‐Echevarría, Luis, María L. Couce, Sergio Lage, et al.. (2013). Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: Impact on growth in PKU. Molecular Genetics and Metabolism. 109(4). 331–338. 23 indexed citations
19.
Blasco‐Alonso, Javier, et al.. (2011). Citrulina plasmática como marcador de pérdida de masa enterocitaria en la enfermedad celíaca en la infancia. Nutrición Hospitalaria. 26(4). 807–813. 3 indexed citations
20.
Martínez‐Costa, Cecilia, et al.. (2011). Consensus on paediatric enteral nutrition access: a document approved by SENPE/SEGHNP/ANECIPN/SECP.. PubMed. 26(1). 1–15. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026